|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01830 PERFECT MEDICAL
Nominal 
1.420 +0.010 (+0.709%) | 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | |
| Turnover | 485,880 | -21.667% | 1,127,863 | 1,393,339 | 1,389,261 | 1,349,971 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 110,435 | -30.944% | 252,549 | 383,723 | 391,456 | 378,153 | |
| Taxation | (19,604) | -31.397% | (46,179) | (73,324) | (75,818) | (72,908) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 3,973 | -58.179% | 525 | 5,401 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 94,804 | -32.689% | 206,895 | 315,800 | 315,638 | 305,245 | |
| 2025/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | |
| Net Finance Costs / (Income) | 573 | -- | (913) | (1,342) | 4,608 | 14,349 |
| Depreciation & Amortisation | 83,576 | -8.702% | 178,341 | 201,962 | 223,593 | 219,046 |
| Directors' Emoluments | -- | -- | 43,227 | 40,807 | 42,977 | 36,203 |
| 2025/09 - Interim | %Chg (Compare to Interim) | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/09 - Interim | %Chg (Compare to Interim) | 2025/03 | 2024/03 | 2023/03 | 2022/03 | |
| EPS (cts) | 7.500 | -33.036% | 16.500 | 25.100 | 25.300 | 24.800 |
| DPS (cts) | 7.600 | -- | 16.600 | 31.500 | 30.000 | 24.800 |
| Dividend Payout Ratio (%) | 101.333% | -- | 100.606% | 125.498% | 118.577% | 100.000% |
| Cash flow per share ($) | -- | -- | 0.265 | 0.396 | 0.449 | 0.418 |
| NBV per share ($) | 0.341 | -- | 0.302 | 0.396 | 0.487 | 0.399 |
| Remarks: | Real time quote last updated: 10/12/2025 11:36 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 94,804 |
| %Change | -32.689% |
| EPS / (LPS) | HKD 0.075 |
| NBV Per Share ($) | HKD 0.341 |